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strate selective up regulation of atrial IP3R Ca2+ release channel mRNA
levels. Increased atrial IP3R expression may contribute to the molecular
substrate for AF arrfnythmogenesis.
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m7036 VascularEndothelialGrowthFactoris UpregulatedbyHydrogenPeroxidein VascularSmoothMuscle
CellsandOverexpressedinAtheroscleroticTissue
J. Ruaf, Z.Y. Hu, L.-Y.Yin, F. Li, G.N. Rae, M.S. Runge, C. Patterson.
Universiryof TexaaMedical Branch at Galveston, Ga/veston, TX, USA
Neovascularization and vascular cell mitosis are hallmarks of naointimal for-
mation in atherosclerotic plaques and restenotic lesions. Vascular endothe-
Iial growth factor (VEGF) promotes neovascular growth, whereas oxidative
stress is a potent factor in vascular proliferation. To investigate the mecha-
nisms of neovascular formation we treated rat vascular smooth muscle cells
(VSMC) with hydrogen peroxide (HP). Northern blot analysis demonstrated a
dose-dependent (20 to 500 KM) and time-dependent (0.5 to 6 h) increase in
VEGF mRNA with a maximum of 10-fold at 3 h (200 KM HP). As determined
by immunoblotfing and ELISA, VEGF protein expression and secretion were
similarly increased. Human umbilical vein endothelial cells (HUVEC) were
treated with conditioned medium from VSMC incubated with 200 #M HP for
4 h. DNA synthesis, measured by thymidine incorporation, was increased
by 1.7-fold compared to controls, an effect that was blocked by neutralizing
anti-VEGF antibody. The effect of HP on VEGF expression and induction
of HUVEC DNA synthesis by conditioned medium could be inhibited by the
tyrosine-kinase inhibitor, genestein. HP had no effeci on the expression of
the VEGF receptor KDR/flk-l in HUVEC. Immunohistochemicd staining of
aortic sections from balloon-injured baboons demonstrated increased VEGF
expression in the neointima compared to controls. Together,our data suggest
that HP is an indirect inducer of endothelial cell growth through release of
the angiogenic factor VEGF from VSMC and that oxidative stress is a factor
in atherosclerotic neovascularization.
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m7041 ReducedTestTimebyEarlyIdentificationofPatienteRequiringAtropineDuringDobutsmine
StressEchocardiography
T.J. Lewandowski, W.F.Armstrong, D.S. Bach. Urriversityof Michigan, Ann
Artro< Ml, USA
Atropine (AT) is used in patients with inadequate heart rate (HR) response
duflng dobutamine stress echocardiographY.The purpose of our study was:
1) to prospectively test an algorithm for early identification of pts requiring
AT,and 2) to study the effect of early AT administration on test duration. Two-
hundred and nineteen pts were randomized to recaive either conventional
AT at peak infusion if HR <100 (LATE) or AT beginning at the end of the
second stage (20 @kgJmin) if HR <70 (EARLY). AT was required in 66
pts; 35 received AT IATE and 51 were randomized to receive AT EARLY.Of
the 51 EARLY pts receiving AT,62% met criteria for and received AT early,
while 18% were missed by the algorithm and received AT at peak. AT dose
was 0.80 + 0.38 mg in EARLY pts and 0.39 + 0.20 mg in LATE pts. Despite
attaining a greater AHR, test duration was reduced 1.3 min (9%, p = 0.01).
The Y. of AHR achieved vs elapsed time was plotted for both groups and
compared to 133 pts who did not receive AT.
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In conclusion, pts who require AT during dobutamine echocardiography
can be reliably identified before peak stress. Early AT use provided a more
balanced physiologic stress and reduced total exposure to dobutamine, thus
decreasing test duration and potentially increasing test efficiency.
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1704+1 AtroPineisnotNecessarYforDobutsmineStress
Echocardiography
P.Desai, K. Conners, R. Conant, S. Shapiro, L. Ginzton. Harbor-UCLA
Medical Centec Torrance,CA, USA
Dobutamine (DOB) is used to detect myocardial ischemia. When DOB fails
to reach the target heart rate (HR) atropine is often added. Hypothesis:
atropine will not increase the frequency of ischemia during DOB stress
echocardiography (DSE). Methods: From January, 1994 to August, 1996,
239 patients (pts) had DSE to diagnose ischemia. DOB was given (5-50)
mc@k@min.Atropine (0.5-2.0 mg) was added at peak DOB if the HR was
<65% of the age-predicted maximal HR. Images were recorded at baseline,
at peak DOB and at atropine’s peak HR. Wall motion abnormalities (WMA)
were scored by 2 echocardiographere blinded to all other data. Ischemia was
defined as new or worsening WMA. Results: 114/239 pts received atropine.
Of these 70 tests were normal, and 44 abnormal. No tests negative with DOB
became positive after atropine. Only 4 pts had worse WMA with atropine,
changing the result from single-vessel (SVD) to multiveeeel (MVD) disease.
Baseline Peak DOB Peak Atropine
HR 73* 15 113 & 23* 130+ 15**
Normal 74 70 70
IschemicSVD 14 14 lot
IechemicMVD 22 30 34t
“p <0.001vs Baseline”’ p <0.001 vs peak DOB t p = NS vs DOB
Conclusions.’During DSE adding atropine does not add to the frequency
or extent of WMA. Therefore, atropine may not be needed for DSE.
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~{ FrequencYandEtiolo9YofFal~Ne9ativeResu[*in
a LargeUnselectedPatientPopulationUndergoing
DobutamineStreasEchocardiography
R. Yeleti, M. Al-DalIi, P. Brenneman, DS. Segar, H. Feigenbaum,
S.G. Sawada. Krannefl hrstifute of Cardiobgy Indiana University
/rrdiarrspo/is,hrd, USA
DSE has demonstrated a high sensitivity for the detection of coronary arIery
disease (CAD) in selected patient populations. To determine the sensitivity
and causes of false negative studias in a large unselected population, the
resultsof DSE in2898 patients were reviewed. Methods: Of the2698 patients
who underwent DSE, 565 underwent coronary angiography (CA) within six
months of DSE. DSE was considered positive in the preaence of a resting
wall motion abnormality (WMA) or a stress induced WMA. Significant CAD
was defined as a iuminal tIarrOWhg Of >50~o in a ITIaJOr @SrdkSl i3_kXJf.
Resu/ts:The sensitivity of DSEfordetecting CAD in all 565 patients was 94%
and the specificity was 62%. In the 222 patients without resting WMA, the
sensitivity wee 83% with 28 false negative exama. The CA of these patients
were reviewed to identify potential causes for the false negative teats: 13
patients had lesions with >50% but <70% stenoais; 7 had lesiona supplied
by collaterals; 4 had disease in distal vessels; and 2 had isolated circumflex
artety disease. Nineteen of the 26 had submaximal atress tests. Corrc/uaions:
In a large unselected patient population, DSE had reasonable sensitivity
for the datection of CAD. Patients with false negative exams frequently
had submaximal studies with mild to moderate CAD (<70% stenoais, distal
disease, or lesions supplied by collaterals).
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D7044 SubmaximalResponseeto DobutemineStreesAreUnhelpfulin PredictingSubsequentCardiacEvents
R. Banal, M.-A. Secknus, R. Mehte, MS. Lauer, T. MarWick. C/eve/and
Clinic Foundation, C/eve/and, OH, USA
Exercise tests are considered submaximal (SMX) if pts do not attain target
heartrate (ie <85% max age-predicted). The significance of a submaximal
(SMX) response during dobutamine echo (DbE) is unclear. Of 1772 pts
undergoing standard DbE (Db to peak 40 @r@min with atropine to 1 mg)
from 1991-4, 255 pts (14%) had a SMX response and were followed for 2
years.
Resu/ts; Pfs with SMX were of similar age (82 + 13 vs 64 + 12 y) and
gender (55% vs 57% men) to the remainder. Resting heart-rate (73 + 13
vs 75 + 14) and SBP (144 + 26 vs 148 + 27) were comparable. Pts with
SMX-DbE demonstrated ischernia (EC) in 46 pta (18%); 20 had coronaty
